{"id":"https://openalex.org/W2003804399","doi":"https://doi.org/10.1016/j.euroneuro.2014.08.016","title":"Audio-digital recordings used for independent confirmation of site-based MADRS interview scores","display_name":"Audio-digital recordings used for independent confirmation of site-based MADRS interview scores","publication_year":2014,"publication_date":"2014-09-06","ids":{"openalex":"https://openalex.org/W2003804399","doi":"https://doi.org/10.1016/j.euroneuro.2014.08.016","mag":"2003804399","pmid":"https://pubmed.ncbi.nlm.nih.gov/25239474"},"language":"en","primary_location":{"id":"doi:10.1016/j.euroneuro.2014.08.016","doi":"https://doi.org/10.1016/j.euroneuro.2014.08.016","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.euroneuro.2014.08.016","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0924977X14002508/pdf","source":{"id":"https://openalex.org/S168041952","display_name":"European Neuropsychopharmacology","issn_l":"0924-977X","issn":["0924-977X","1873-7862"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Neuropsychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.sciencedirect.com/science/article/pii/S0924977X14002508/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071455209","display_name":"Steven D. Targum","orcid":"https://orcid.org/0000-0003-1054-5197","observed_orcids":["https://orcid.org/0000-0003-1054-5197"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Steven D. Targum","raw_affiliation_strings":["Clintara LLC, Boston, MA, USA. Electronic address: sdtargum@yahoo.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clintara LLC, Boston, MA, USA. Electronic address: sdtargum@yahoo.com","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077108827","display_name":"Jo Cara Pendergrass","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Cara Pendergrass","raw_affiliation_strings":["Clintara LLC, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clintara LLC, Boston, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006525181","display_name":"Chelsea K. Toner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chelsea Toner","raw_affiliation_strings":["Clintara LLC, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clintara LLC, Boston, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004004308","display_name":"Mahnaz Asgharnejad","orcid":"https://orcid.org/0000-0001-8060-2148","observed_orcids":["https://orcid.org/0000-0001-8060-2148"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mahnaz Asgharnejad","raw_affiliation_strings":["UCB Biosciences Inc. (formerly CeNeRx Pharmaceuticals), Raleigh, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCB Biosciences Inc. (formerly CeNeRx Pharmaceuticals), Raleigh, NC, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005110920","display_name":"DANIEL J. BURCH","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1296342797","display_name":"Pharmaceutical Product Development (United States)","ror":"https://ror.org/01sjx9496","country_code":"US","type":"company","lineage":["https://openalex.org/I1296342797"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel J. Burch","raw_affiliation_strings":["PPD Inc. (formerly CeNeRx Pharmaceuticals), Wilmington, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PPD Inc. (formerly CeNeRx Pharmaceuticals), Wilmington, NC, USA","institution_ids":["https://openalex.org/I1296342797"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5071455209"],"corresponding_institution_ids":[],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":{"value":3000,"currency":"USD","value_usd":3000},"fwci":0.9755,"has_fulltext":true,"cited_by_count":16,"citation_normalized_percentile":{"value":0.81305446,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"24","issue":"11","first_page":"1760","last_page":"1766"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13309","display_name":"Reliability and Agreement in Measurement","score":0.9193999767303467,"subfield":{"id":"https://openalex.org/subfields/1804","display_name":"Statistics, Probability and Uncertainty"},"field":{"id":"https://openalex.org/fields/18","display_name":"Decision Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T13309","display_name":"Reliability and Agreement in Measurement","score":0.9193999767303467,"subfield":{"id":"https://openalex.org/subfields/1804","display_name":"Statistics, Probability and Uncertainty"},"field":{"id":"https://openalex.org/fields/18","display_name":"Decision Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.02319999970495701,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12848","display_name":"Psychological Testing and Assessment","score":0.006800000090152025,"subfield":{"id":"https://openalex.org/subfields/3202","display_name":"Applied Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/montgomery-asberg-depression-rating-scale","display_name":"Montgomery-Asberg Depression Rating Scale","score":0.847000002861023},{"id":"https://openalex.org/keywords/rater-reliability","display_name":"rater reliability","score":0.6230000257492065},{"id":"https://openalex.org/keywords/treatment-resistant-depression","display_name":"treatment-resistant depression","score":0.7739999890327454},{"id":"https://openalex.org/keywords/antidepressant-trials","display_name":"antidepressant trials","score":0.7689999938011169},{"id":"https://openalex.org/keywords/quality-assurance","display_name":"quality assurance","score":0.5429999828338623},{"id":"https://openalex.org/keywords/kappa-agreement","display_name":"kappa agreement","score":0.5070000290870667},{"id":"https://openalex.org/keywords/treatment-response-assessment","display_name":"treatment response assessment","score":0.49399998784065247}],"concepts":[{"id":"https://openalex.org/C2778724333","wikidata":"https://www.wikidata.org/wiki/Q14401","display_name":"Kappa","level":2,"score":0.7319203615188599},{"id":"https://openalex.org/C83849319","wikidata":"https://www.wikidata.org/wiki/Q7295720","display_name":"Rating scale","level":2,"score":0.5915098786354065},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5654025673866272},{"id":"https://openalex.org/C61863361","wikidata":"https://www.wikidata.org/wiki/Q470749","display_name":"Inter-rater reliability","level":3,"score":0.5292852520942688},{"id":"https://openalex.org/C43214815","wikidata":"https://www.wikidata.org/wiki/Q7310987","display_name":"Reliability (semiconductor)","level":3,"score":0.523697018623352},{"id":"https://openalex.org/C176217482","wikidata":"https://www.wikidata.org/wiki/Q860554","display_name":"Metric (unit)","level":2,"score":0.45760369300842285},{"id":"https://openalex.org/C163864269","wikidata":"https://www.wikidata.org/wiki/Q1107106","display_name":"Cohen's kappa","level":2,"score":0.4232771396636963},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.3888856768608093},{"id":"https://openalex.org/C548259974","wikidata":"https://www.wikidata.org/wiki/Q569965","display_name":"Audiology","level":1,"score":0.3340231776237488},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.23646730184555054},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.15623071789741516},{"id":"https://openalex.org/C119857082","wikidata":"https://www.wikidata.org/wiki/Q2539","display_name":"Machine learning","level":1,"score":0.12822836637496948},{"id":"https://openalex.org/C138496976","wikidata":"https://www.wikidata.org/wiki/Q175002","display_name":"Developmental psychology","level":1,"score":0.12729376554489136},{"id":"https://openalex.org/C163258240","wikidata":"https://www.wikidata.org/wiki/Q25342","display_name":"Power (physics)","level":2,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C41895202","wikidata":"https://www.wikidata.org/wiki/Q8162","display_name":"Linguistics","level":1,"score":0.0},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0},{"id":"https://openalex.org/C21547014","wikidata":"https://www.wikidata.org/wiki/Q1423657","display_name":"Operations management","level":1,"score":0.0},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003308","descriptor_name":"Copying Processes","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006571","descriptor_name":"Heterocyclic Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007407","descriptor_name":"Interviews as Topic","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D008996","descriptor_name":"Monoamine Oxidase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011594","descriptor_name":"Psychometrics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015203","descriptor_name":"Reproducibility of Results","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D061218","descriptor_name":"Depressive Disorder, Treatment-Resistant","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.euroneuro.2014.08.016","doi":"https://doi.org/10.1016/j.euroneuro.2014.08.016","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.euroneuro.2014.08.016","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0924977X14002508/pdf","source":{"id":"https://openalex.org/S168041952","display_name":"European Neuropsychopharmacology","issn_l":"0924-977X","issn":["0924-977X","1873-7862"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Neuropsychopharmacology","raw_type":"journal-article"},{"id":"pmid:25239474","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25239474","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.euroneuro.2014.08.016","doi":"https://doi.org/10.1016/j.euroneuro.2014.08.016","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.euroneuro.2014.08.016","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0924977X14002508/pdf","source":{"id":"https://openalex.org/S168041952","display_name":"European Neuropsychopharmacology","issn_l":"0924-977X","issn":["0924-977X","1873-7862"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Neuropsychopharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.46810001134872437,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.6000000238418579,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2003804399.pdf","grobid_xml":"https://content.openalex.org/works/W2003804399.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W79407965","https://openalex.org/W1863372081","https://openalex.org/W1996080500","https://openalex.org/W2018642809","https://openalex.org/W2020672348","https://openalex.org/W2022098945","https://openalex.org/W2027238888","https://openalex.org/W2029553347","https://openalex.org/W2040716668","https://openalex.org/W2048626722","https://openalex.org/W2049571898","https://openalex.org/W2050497702","https://openalex.org/W2066140372","https://openalex.org/W2069138677","https://openalex.org/W2070468494","https://openalex.org/W2071735605","https://openalex.org/W2072633755","https://openalex.org/W2073526412","https://openalex.org/W2087506222","https://openalex.org/W2094608167","https://openalex.org/W2106670347","https://openalex.org/W2111663098","https://openalex.org/W2114613490","https://openalex.org/W2114691160","https://openalex.org/W2129476280","https://openalex.org/W2131823335","https://openalex.org/W2586479964","https://openalex.org/W2797726893","https://openalex.org/W3022868799","https://openalex.org/W4246758154"],"related_works":["https://openalex.org/W2910919733","https://openalex.org/W2810150585","https://openalex.org/W4404581374","https://openalex.org/W2011526782","https://openalex.org/W3163007046","https://openalex.org/W6941338784","https://openalex.org/W1992333267","https://openalex.org/W2069138677","https://openalex.org/W2092373457","https://openalex.org/W4385883250"],"abstract_inverted_index":{"Signal":[0],"detection":[1],"requires":[2],"ratings":[3,27,132,164,174],"reliability":[4,165],"throughout":[5],"a":[6,16,23,45,51,167,177,193],"clinical":[7],"trial.":[8],"The":[9,101],"confirmation":[10],"of":[11,26,37,50,120,126,137,171],"site-based":[12,35,70,95,122,138,145,173],"rater":[13,21,96,190],"scores":[14,64,97,184],"by":[15],"second,":[17],"independent":[18,131],"and":[19,71,78,84,90,109,140,162,185,188],"blinded":[20,102],"is":[22,129,166],"reasonable":[24],"metric":[25],"reliability.":[28],"We":[29],"used":[30],"audio-digital":[31],"pens":[32],"to":[33,143,182,186],"record":[34],"interviews":[36,139],"the":[38,94,99,114,121,135,144],"Montgomery-Asberg":[39],"Depression":[40],"Rating":[41],"Scale":[42],"(MADRS)":[43],"in":[44,54],"double-blind,":[46],"placebo":[47],"controlled":[48],"trial":[49],"novel":[52],"antidepressant":[53],"treatment":[55,88,115],"resistant":[56],"depressed":[57],"patients.":[58],"Blinded,":[59],"site-independent":[60,72],"raters":[61,73,103],"generated":[62],"\"dual\"":[63],"that":[65,130,158],"revealed":[66],"high":[67,79],"correlations":[68],"between":[69],"(r=0.940":[74],"for":[75,87,112,156],"all":[76],"ratings)":[77],"sensitivity,":[80],"specificity,":[81],"predictive":[82],"values,":[83],"kappa":[85,111],"coefficients":[86],"response":[89,116],"non-response":[91,118],"outcomes":[92,119],"using":[93],"as":[98],"standard.":[100],"achieved":[104],"an":[105],"89.4%":[106],"overall":[107],"accuracy":[108],"0.786":[110],"matching":[113],"or":[117],"raters.":[123],"A":[124],"limitation":[125],"this":[127,148],"method":[128],"depend":[133],"on":[134],"quality":[136,149],"patient":[141],"responses":[142],"interviewers.":[146],"Nonetheless,":[147],"assurance":[150],"strategy":[151,181],"may":[152],"have":[153],"broad":[154],"applicability":[155],"studies":[157],"use":[159],"subjective":[160],"measures":[161],"wherever":[163],"concern.":[168],"\"Dual\"":[169],"scoring":[170],"recorded":[172],"can":[175],"be":[176],"relatively":[178],"unobtrusive":[179],"surveillance":[180],"confirm":[183],"identify":[187],"remediate":[189],"\"outliers\"":[191],"during":[192],"study.":[194]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}